$1,075,369,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Menlo Therapeutics, Inc. Settlement
(NASDAQ: MNLO)
Settlement

Claim Deadline: August 17, 2020

Settlement Fund: $9,500,000

Settlement Class

ALL PERSONS OR ENTITIES THAT PURCHASED OR OTHERWISE ACQUIRED MENLO THERAPEUTICS INC. (“MENLO”  OR THE “COMPANY”) COMMON STOCK PURSUANT OR TRACEABLE TO THE COMPANY’S  REGISTRATION STATEMENT AND PROSPECTUS ISSUED IN CONNECTION WITH MENLO’S  JANUARY 29, 2018 INITIAL PUBLIC OFFERING

Important Documents

Settlement Status

Final Approval

Class Period

January 29, 2018 - November 08, 2018

Settlement Hearing Date

August 14, 2020

Opt-Out Deadline

July 24, 2020

Settlement Website

http://www.menlosecuritieslitigation.com/

Claims Admin

Gilardi & Co. LLC
Menlo Securities Litigation Settlement
c/o Gilardi & Co. LLC
P.O. Box 43350
Providence, RI 02940-3350
+1 866-526-2201
info@menlosecuritieslitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.